GSL’s Roojin Habibi co-authors paper on pharmaceutical sales visits in Canada, France, and United States

December 30, 2016
GSL’s Roojin Habibi co-authors paper on pharmaceutical sales visits in Canada, France, and United States

On December 30thThe Journal of Law, Medicine & Ethics published a paper co-authored by GSL Research Assistant Roojin Habibi titled, “Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United States.” Habibi et al. sought to “contextualize the findings of the Pharmaceuticals Sales Representatives and Patient Safety study” by interviewing members of several identified categories in three leading countries on relevant topics. Overall, the authors discovered that “distinctive regulatory shortcomings included limited awareness of existing standards in Canada; inadequate application of legislation in France; and limits to regulation in the US due to strong protection of freedom of commercial speech.” Read the insightful article in full here.

 

habibi_et_al_2016.pdf373 KB